|
| | Bosutinib Impurity 5 Basic information |
| Product Name: | Bosutinib Impurity 5 | | Synonyms: | Bosutinib isomer 1;3-Quinolinecarbonitrile, 4-[(3,5-dichloro-4-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-;Bosutinib Isomer I (PF-06651481-00);Bosutinib Isomer I | | CAS: | 1391063-17-4 | | MF: | C26H29Cl2N5O3 | | MW: | 530.45 | | EINECS: | | | Product Categories: | | | Mol File: | 1391063-17-4.mol |  |
| | Bosutinib Impurity 5 Chemical Properties |
| solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated) | | form | Solid | | color | White to Light Brown | | Stability: | Stable under recommended storage conditions., Stable Under Recommended Storage C |
| | Bosutinib Impurity 5 Usage And Synthesis |
| Uses | Kinase inhibitors, such as?bosutinib,?are useful cancer drugs but their target specificity is not fully understood. 4-[(3,5-Dichloro-4-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile has been employed as a clinical kinase inhibitor bosutinib to elucidate the recognition mechanism between the ATP-binding site and the compound. |
| | Bosutinib Impurity 5 Preparation Products And Raw materials |
|
